Xsensio is a startup based in Switzerland, most recent round Series A.
Xsensio is a company headquartered in Switzerland. Its most recent tracked round is Series A.
Xsensio develops a Lab-on-Skin™ biochemical sensing platform and highly miniaturized sensing chips for continuous, real-time monitoring of biomarkers (such as inflammation) to enable earlier detection of organ dysfunction in clinical, outpatient and home settings.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.